cp wire

CP Wire Articles

Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases

  • Many pathogens may inhibit or modulate their host’s immune system and thus circumvent immune defense
  • Immune system activating therapies may open transformative opportunities... read more
Tue, 09/4/18 - 09:44 am
On the Heels of $20 Million Funding Round, Macrolide Adds Scientific and Financial Expertise

Macrolide Pharmaceuticals announced on 9/4/18 a leadership expansion that adds significant expertise in drug development, clinical strategy, finance and... read more

Tue, 09/4/18 - 09:28 am
Sunovion Receives Bad News From the FDA About ADHD Drug


Sunovion Pharmaceuticals Inc. (Sunovion) announced on 8/31/18 that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for... read more

Fri, 08/31/18 - 10:42 am
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia


Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental Biologics License Application (sBLA) for Sprycel (dasatinib... read more

Thu, 08/30/18 - 09:44 am
Pfizer Ends Trials for Domagrozumab in Drug for Duchenne Muscular Dystrophy
  • Domagrozumab Ph II study did not meet primary endpoint
  • Pfizer is also developing a gene therapy, PF-06939926, for DMD
  • PF-06939926 has orphan status in the US and Europe... read more
Thu, 08/30/18 - 09:31 am

Pages